A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
Public ClinicalTrials.gov record NCT05747508. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A randomized, double-blind, placebo-controlled dose escalation study to assess the safety and efficacy of pulsed, inhaled nitric oxide (iNO) in subjects with pulmonary fibrosis on long term oxygen therapy.
Study identification
- NCT ID
- NCT05747508
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 85 participants
Conditions and interventions
Conditions
Interventions
- INOpulse® Combination Product
- Placebo Combination Product
- Long Term Follow Up Combination Product
Combination Product
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 29, 2017 (Actual)
- Primary completion
- Nov 22, 2019 (Actual)
- Completion
- Dec 2023 (Estimated)
- Last update posted
- Feb 28, 2023
2017 – 2023
United States locations
- U.S. sites
- 23
- U.S. states
- 18
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Pulmonary Specialists | Phoenix | Arizona | 85012 | — |
| University of California | Los Angeles | California | 90024 | — |
| University of California Davis Health | Sacramento | California | 95817 | — |
| University of Colorado Hospital | Aurora | Colorado | 80045 | — |
| University of Miami | Miami | Florida | 33125 | — |
| Avanza Medical Research Center | Pensacola | Florida | 32503 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Piedmont Healthcare Pulmonary & Critical Care Research | Austell | Georgia | 30106 | — |
| Loyola University | Chicago | Illinois | 60153 | — |
| Norton Pulmonary Specialists | Louisville | Kentucky | 40202-1332 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| The Lung Research Center (St. Luke's) | Chesterfield | Missouri | 63017 | — |
| The University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27517 | — |
| University of Cincinnati College of Medicine | Cincinnati | Ohio | 45267 | — |
| Thomas Jefferson University Korman Respiratory Institute | Philadelphia | Pennsylvania | 19017 | — |
| Temple University Hospital | Philadelphia | Pennsylvania | 19140 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| University of Utah Health Sciences | Salt Lake City | Utah | 84108 | — |
| Inova Heart and Vascular Institute Advanced Lung Disease Clinic | Falls Church | Virginia | 22042 | — |
| Pulmonary Associates of Richmond | Richmond | Virginia | 23229 | — |
| University of Washington Medical Center | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05747508, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 28, 2023 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05747508 live on ClinicalTrials.gov.